Alnylam Pharmaceuticals, Inc. (LON:0HD2)

Alnylam Pharmaceuticals Statistics

Total Valuation

LON:0HD2 has a market cap or net worth of GBP 44.42 billion. The enterprise value is 44.46 billion.

Market Cap	44.42B
Enterprise Value	44.46B

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	132.11M
Shares Outstanding	n/a
Shares Change (YoY)	+4.82%
Shares Change (QoQ)	+5.14%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	100.91%
Float	130.24M

Valuation Ratios

The trailing PE ratio is 1,370.63 and the forward PE ratio is 46.10.

PE Ratio	1,370.63
Forward PE	46.10
PS Ratio	18.60
PB Ratio	255.29
P/TBV Ratio	255.29
P/FCF Ratio	269.74
P/OCF Ratio	224.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 151.61, with an EV/FCF ratio of 269.97.

EV / Earnings	1,371.77
EV / Sales	18.23
EV / EBITDA	151.61
EV / EBIT	221.14
EV / FCF	269.97

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 11.86.

Current Ratio	2.54
Quick Ratio	2.37
Debt / Equity	11.86
Debt / EBITDA	7.18
Debt / FCF	12.53
Interest Coverage	1.63

Financial Efficiency

Return on equity (ROE) is 32.73% and return on invested capital (ROIC) is 5.74%.

Return on Equity (ROE)	32.73%
Return on Assets (ROA)	3.65%
Return on Invested Capital (ROIC)	5.74%
Return on Capital Employed (ROCE)	8.03%
Revenue Per Employee	1.07M
Profits Per Employee	14,534
Employee Count	2,230
Asset Turnover	0.71
Inventory Turnover	6.83

Taxes

Income Tax	-56.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+60.84%
50-Day Moving Average	459.24
200-Day Moving Average	340.39
Relative Strength Index (RSI)	41.49
Average Volume (20 Days)	507

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.51

Income Statement

In the last 12 months, LON:0HD2 had revenue of GBP 2.39 billion and earned 32.41 million in profits. Earnings per share was 0.25.

Revenue	2.39B
Gross Profit	2.00B
Operating Income	196.92M
Pretax Income	-23.76M
Net Income	32.41M
EBITDA	238.82M
EBIT	196.92M
Earnings Per Share (EPS)	0.25

Balance Sheet

The company has 2.03 billion in cash and 2.06 billion in debt, giving a net cash position of -36.22 million.

Cash & Cash Equivalents	2.03B
Total Debt	2.06B
Net Cash	-36.22M
Net Cash Per Share	n/a
Equity (Book Value)	174.00M
Book Value Per Share	1.32
Working Capital	1.78B

Cash Flow

In the last 12 months, operating cash flow was 197.79 million and capital expenditures -33.10 million, giving a free cash flow of 164.68 million.

Operating Cash Flow	197.79M
Capital Expenditures	-33.10M
Free Cash Flow	164.68M
FCF Per Share	n/a

Margins

Gross margin is 83.90%, with operating and profit margins of 8.25% and 1.36%.

Gross Margin	83.90%
Operating Margin	8.25%
Pretax Margin	-1.00%
Profit Margin	1.36%
EBITDA Margin	10.00%
EBIT Margin	8.25%
FCF Margin	6.90%

Dividends & Yields

LON:0HD2 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.82%
Shareholder Yield	-4.82%
Earnings Yield	0.07%
FCF Yield	0.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HD2 has an Altman Z-Score of 4.46 and a Piotroski F-Score of 5.

Altman Z-Score	4.46
Piotroski F-Score	5